Nevertheless, additional characterization experiments are required to determine whether ADAM28 could have diagnostic and/or prognostic potential in at least a subset of pediatric B-ALL cases. This evidence concerns the gene ADAM28 and precursor B-cell acute lymphoblastic leukemia.